Global DNA 5hmC and CK195hmC+ Contents: A Promising Biomarker for Predicting Prognosis in Small Hepatocellular Carcinoma

Background: 5-Hydroxymethylcytosine (5hmC) with dynamic existence possesses multiple regulatory functions. Whereas, 5hmC’s impact on small hepatocellular carcinoma (SHCC) remains unclear. The present work focused on characterizing 5hmC content within SHCC and assessing the possibility of using globa...

Full description

Saved in:
Bibliographic Details
Published inCurrent oncology (Toronto) Vol. 28; no. 5; pp. 3758 - 3770
Main Authors Jiang, Jinhua, Yan, Tinghua, Guo, Fang
Format Journal Article
LanguageEnglish
Published MDPI 28.09.2021
MDPI AG
Subjects
5hmC
CK19
DNA methylation
prognosis
small hepatocellular carcinoma
Online AccessGet full text

Cover

Abstract Background: 5-Hydroxymethylcytosine (5hmC) with dynamic existence possesses multiple regulatory functions. Whereas, 5hmC’s impact on small hepatocellular carcinoma (SHCC) remains unclear. The present work focused on characterizing 5hmC content within SHCC and assessing the possibility of using global genomic 5hmC level as the predicative factor of clinical outcome. Methods: This study applied ultra-high-performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) in measuring 5mC, 5fC and 5hmC contents. In addition, immunohistochemistry (IHC) was adopted to measure CK19 and 5hmC contents. Results: Research showed 5mC, 5hmC, and 5fC contents from global genomics of SHCC reduced extensively compared with healthy samples (p < 0.001). Moreover, SHCC was associated with lymph node metastasis (LNM). Greater 5mC and 5hmC levels were observed in non-metastasis group compared with the metastasis group (p < 0.001). Correlation analysis between the HBV DNA level and 5mC, 5fC and 5hmC levels exhibited that HBV DNA was associated with 5mC, 5hmC, and 5fC content reduction, which was verified in the cytological experiments. Moreover, 5hmC content had a negative correlation with the expression level of CK19 in SHCC. The decrease in 5hmC and CK19 containing 5hmC positive cell (called CK195hmC+) should be ascribed to the bad prognosis among SHCC patients. Conclusions: The contents of 5hmC and CK195hmC+ of genomic DNA might be adopted for predicting SHCC survival as an important biomarker.
AbstractList 5-Hydroxymethylcytosine (5hmC) with dynamic existence possesses multiple regulatory functions. Whereas, 5hmC's impact on small hepatocellular carcinoma (SHCC) remains unclear. The present work focused on characterizing 5hmC content within SHCC and assessing the possibility of using global genomic 5hmC level as the predicative factor of clinical outcome.BACKGROUND5-Hydroxymethylcytosine (5hmC) with dynamic existence possesses multiple regulatory functions. Whereas, 5hmC's impact on small hepatocellular carcinoma (SHCC) remains unclear. The present work focused on characterizing 5hmC content within SHCC and assessing the possibility of using global genomic 5hmC level as the predicative factor of clinical outcome.This study applied ultra-high-performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) in measuring 5mC, 5fC and 5hmC contents. In addition, immunohistochemistry (IHC) was adopted to measure CK19 and 5hmC contents.METHODSThis study applied ultra-high-performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) in measuring 5mC, 5fC and 5hmC contents. In addition, immunohistochemistry (IHC) was adopted to measure CK19 and 5hmC contents.Research showed 5mC, 5hmC, and 5fC contents from global genomics of SHCC reduced extensively compared with healthy samples (p < 0.001). Moreover, SHCC was associated with lymph node metastasis (LNM). Greater 5mC and 5hmC levels were observed in non-metastasis group compared with the metastasis group (p < 0.001). Correlation analysis between the HBV DNA level and 5mC, 5fC and 5hmC levels exhibited that HBV DNA was associated with 5mC, 5hmC, and 5fC content reduction, which was verified in the cytological experiments. Moreover, 5hmC content had a negative correlation with the expression level of CK19 in SHCC. The decrease in 5hmC and CK19 containing 5hmC positive cell (called CK195hmC+) should be ascribed to the bad prognosis among SHCC patients.RESULTSResearch showed 5mC, 5hmC, and 5fC contents from global genomics of SHCC reduced extensively compared with healthy samples (p < 0.001). Moreover, SHCC was associated with lymph node metastasis (LNM). Greater 5mC and 5hmC levels were observed in non-metastasis group compared with the metastasis group (p < 0.001). Correlation analysis between the HBV DNA level and 5mC, 5fC and 5hmC levels exhibited that HBV DNA was associated with 5mC, 5hmC, and 5fC content reduction, which was verified in the cytological experiments. Moreover, 5hmC content had a negative correlation with the expression level of CK19 in SHCC. The decrease in 5hmC and CK19 containing 5hmC positive cell (called CK195hmC+) should be ascribed to the bad prognosis among SHCC patients.The contents of 5hmC and CK195hmC+ of genomic DNA might be adopted for predicting SHCC survival as an important biomarker.CONCLUSIONSThe contents of 5hmC and CK195hmC+ of genomic DNA might be adopted for predicting SHCC survival as an important biomarker.
Background: 5-Hydroxymethylcytosine (5hmC) with dynamic existence possesses multiple regulatory functions. Whereas, 5hmC’s impact on small hepatocellular carcinoma (SHCC) remains unclear. The present work focused on characterizing 5hmC content within SHCC and assessing the possibility of using global genomic 5hmC level as the predicative factor of clinical outcome. Methods: This study applied ultra-high-performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) in measuring 5mC, 5fC and 5hmC contents. In addition, immunohistochemistry (IHC) was adopted to measure CK19 and 5hmC contents. Results: Research showed 5mC, 5hmC, and 5fC contents from global genomics of SHCC reduced extensively compared with healthy samples ( p < 0.001). Moreover, SHCC was associated with lymph node metastasis (LNM). Greater 5mC and 5hmC levels were observed in non-metastasis group compared with the metastasis group ( p < 0.001). Correlation analysis between the HBV DNA level and 5mC, 5fC and 5hmC levels exhibited that HBV DNA was associated with 5mC, 5hmC, and 5fC content reduction, which was verified in the cytological experiments. Moreover, 5hmC content had a negative correlation with the expression level of CK19 in SHCC. The decrease in 5hmC and CK19 containing 5hmC positive cell (called CK19 5hmC+ ) should be ascribed to the bad prognosis among SHCC patients. Conclusions: The contents of 5hmC and CK19 5hmC+ of genomic DNA might be adopted for predicting SHCC survival as an important biomarker.
Background: 5-Hydroxymethylcytosine (5hmC) with dynamic existence possesses multiple regulatory functions. Whereas, 5hmC’s impact on small hepatocellular carcinoma (SHCC) remains unclear. The present work focused on characterizing 5hmC content within SHCC and assessing the possibility of using global genomic 5hmC level as the predicative factor of clinical outcome. Methods: This study applied ultra-high-performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) in measuring 5mC, 5fC and 5hmC contents. In addition, immunohistochemistry (IHC) was adopted to measure CK19 and 5hmC contents. Results: Research showed 5mC, 5hmC, and 5fC contents from global genomics of SHCC reduced extensively compared with healthy samples (p < 0.001). Moreover, SHCC was associated with lymph node metastasis (LNM). Greater 5mC and 5hmC levels were observed in non-metastasis group compared with the metastasis group (p < 0.001). Correlation analysis between the HBV DNA level and 5mC, 5fC and 5hmC levels exhibited that HBV DNA was associated with 5mC, 5hmC, and 5fC content reduction, which was verified in the cytological experiments. Moreover, 5hmC content had a negative correlation with the expression level of CK19 in SHCC. The decrease in 5hmC and CK19 containing 5hmC positive cell (called CK195hmC+) should be ascribed to the bad prognosis among SHCC patients. Conclusions: The contents of 5hmC and CK195hmC+ of genomic DNA might be adopted for predicting SHCC survival as an important biomarker.
Author Yan, Tinghua
Guo, Fang
Jiang, Jinhua
AuthorAffiliation 3 Department of Interventional Oncology, The First Clinical Medical College of Jinan University, Guangzhou 510660, China; tinghua@stu.jnu.edu.cn
1 Key Laboratory of Systems Biomedicine, Ministry of Education, Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai 200240, China; carli8880@sjtu.edu.cn
2 Department of Interventional Oncology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200127, China
AuthorAffiliation_xml – name: 3 Department of Interventional Oncology, The First Clinical Medical College of Jinan University, Guangzhou 510660, China; tinghua@stu.jnu.edu.cn
– name: 1 Key Laboratory of Systems Biomedicine, Ministry of Education, Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai 200240, China; carli8880@sjtu.edu.cn
– name: 2 Department of Interventional Oncology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200127, China
Author_xml – sequence: 1
  givenname: Jinhua
  surname: Jiang
  fullname: Jiang, Jinhua
– sequence: 2
  givenname: Tinghua
  surname: Yan
  fullname: Yan, Tinghua
– sequence: 3
  givenname: Fang
  surname: Guo
  fullname: Guo, Fang
BookMark eNp1kl1rFTEQhoO02A_9Ad7lUpBT87WbXS-E41rb0qKCeh1ms8lpajY5TXZL_fdmPRWsIgSSzMz7ZPIyR2gvxGAQekHJCectea3nlGLQ0bOGVIQz-gQdUkmblZSs3fvjfICOcr4hhHMp5VN0wEVdwrw9RPdnPvbg8fuPa1xdjx2GMODukrbL5RXuYphMmPIbvMafUxxddmGD37k4QvpuErYxlbgZnJ6WRCnZhJhdxi7gLyN4j8_NFqaojfezh4Q7SNqFIn-G9i34bJ4_7Mfo24fTr9356urT2UW3vlppLtm0aoymghpjbcN62mtJpawsa3QtGK-FNRVINjDZt6QCS6UV1DZWVkMPA4Ve82N0seMOEW7UNrnS-Q8VwalfgZg2CtLktDeqbo2oQTMh-rYsKI_wVlBGCSV9W0Nhvd2xtnM_mkEXZxL4R9DHmeCu1SbeqabiovhdAC8fACneziZPqji6eAPBxDkrVjVClG9VrJTKXalOMedkrNJugsnFhey8okQtM6D-mYGipH8pfzf4f81PkEO5DA
CitedBy_id crossref_primary_10_1369_00221554231190437
crossref_primary_10_1038_s41420_024_01935_2
crossref_primary_10_1016_j_trac_2023_117306
crossref_primary_10_1186_s13148_022_01323_6
crossref_primary_10_3892_or_2022_8430
crossref_primary_10_1002_ctm2_70066
Cites_doi 10.1186/s12885-017-3431-1
10.1016/j.lungcan.2010.04.017
10.1002/hep.28493
10.1186/s13072-017-0170-0
10.1186/s13072-019-0284-7
10.1016/j.molcel.2012.03.014
10.1136/gutjnl-2012-304351
10.1148/radiol.2016152120
10.1016/S0140-6736(18)30010-2
10.2217/epi.14.39
10.1016/j.bbrc.2014.08.029
10.1002/hep.30211
10.1159/000365197
10.1158/1078-0432.CCR-17-1958
10.1002/jcb.26586
10.1002/hep.26622
10.1016/j.cell.2013.02.004
10.1038/labinvest.2010.161
10.1007/s00401-018-1844-9
10.1111/his.13506
10.1186/s13148-015-0133-x
10.1002/hep.24559
10.1159/000443995
10.3322/caac.21590
10.1007/978-3-0348-0837-8_4
10.3390/bioengineering6030073
10.1016/j.neures.2018.09.010
10.1371/journal.pone.0091330
10.1016/j.cld.2010.08.003
10.1038/nrclinonc.2015.103
10.3390/cancers12102776
10.1038/nm.3336
10.1593/tlo.13523
10.1158/1078-0432.CCR-14-1936
10.1097/01.sla.0000128687.59439.d6
10.2217/epi-2017-0077
10.1111/j.1365-2559.2006.02468.x
10.1186/s13148-018-0540-x
10.1186/s12885-016-2949-y
10.1002/hep.22506
10.1002/hep.30146
10.2217/fon.09.147
10.1016/j.gde.2016.01.004
10.1080/15384101.2017.1346761
10.3892/ol.2015.3044
10.1007/s00270-016-1314-5
ContentType Journal Article
Copyright 2021 by the authors. 2021
Copyright_xml – notice: 2021 by the authors. 2021
DBID AAYXX
CITATION
7X8
5PM
DOA
DOI 10.3390/curroncol28050321
DatabaseName CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals - May need to register for free articles
DatabaseTitle CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic


CrossRef
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1718-7729
EndPage 3770
ExternalDocumentID oai_doaj_org_article_69e46ac244b94b9a8c6394121010b96a
PMC8534723
10_3390_curroncol28050321
GroupedDBID ---
04C
29F
2WC
53G
5GY
5VS
6PF
AAWTL
AAYXX
ABDBF
ACGFS
ACUHS
ADBBV
AENEX
AFZYC
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BMSDO
CITATION
CS3
DIK
DU5
E3Z
EBD
EBS
EIHBH
EJD
ESX
F5P
GROUPED_DOAJ
HYE
KQ8
MODMG
OK1
OVT
RNS
RPM
TR2
TUS
7X8
5PM
ID FETCH-LOGICAL-c372t-8ec141eeff82b1bc71775f28c642364fe5a72d27b905af17f41f8f75dbad1abc3
IEDL.DBID DOA
ISSN 1718-7729
1198-0052
IngestDate Wed Aug 27 01:29:26 EDT 2025
Thu Aug 21 13:13:02 EDT 2025
Fri Jul 11 09:06:57 EDT 2025
Tue Jul 01 02:54:37 EDT 2025
Thu Apr 24 23:01:28 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
License https://creativecommons.org/licenses/by/4.0
Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c372t-8ec141eeff82b1bc71775f28c642364fe5a72d27b905af17f41f8f75dbad1abc3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://doaj.org/article/69e46ac244b94b9a8c6394121010b96a
PMID 34677239
PQID 2584436452
PQPubID 23479
PageCount 13
ParticipantIDs doaj_primary_oai_doaj_org_article_69e46ac244b94b9a8c6394121010b96a
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8534723
proquest_miscellaneous_2584436452
crossref_citationtrail_10_3390_curroncol28050321
crossref_primary_10_3390_curroncol28050321
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20210928
PublicationDateYYYYMMDD 2021-09-28
PublicationDate_xml – month: 9
  year: 2021
  text: 20210928
  day: 28
PublicationDecade 2020
PublicationTitle Current oncology (Toronto)
PublicationYear 2021
Publisher MDPI
MDPI AG
Publisher_xml – name: MDPI
– name: MDPI AG
References Kawai (ref_47) 2015; 21
Hasegawa (ref_34) 2015; 94
Matthias (ref_19) 2013; 6
Mallol (ref_38) 2019; 12
Ogura (ref_29) 2014; 452
Yoneda (ref_45) 2011; 91
Tsujita (ref_7) 2013; 60
Hyun (ref_4) 2016; 39
Jeschke (ref_20) 2016; 36
Vertino (ref_33) 2012; 45
Hlady (ref_27) 2019; 69
Cheng (ref_30) 2016; 3
Yoon (ref_51) 2011; 71
Lin (ref_24) 2014; 29
Lee (ref_39) 2018; 119
Roskams (ref_42) 2010; 14
Lewis (ref_23) 2017; 9
Storebjerg (ref_11) 2018; 10
Liu (ref_10) 2017; 10
Liu (ref_25) 2019; 69
Siegel (ref_2) 2020; 70
Govaere (ref_17) 2014; 63
Rodger (ref_14) 2014; 6
Gillanders (ref_48) 2004; 239
Wang (ref_21) 2018; 15
Llovet (ref_16) 2015; 12
Kantidze (ref_12) 2017; 16
Civan (ref_3) 2016; 279
Spruijt (ref_15) 2013; 152
Iwagawa (ref_37) 2019; 138
Giannini (ref_6) 2014; 59
Makise (ref_35) 2018; 73
ref_31
Dai (ref_8) 2015; 9
Forner (ref_1) 2018; 391
Lei (ref_28) 2009; 25
Llovet (ref_5) 2008; 48
Michela (ref_18) 2020; 12
Tucker (ref_13) 2018; 24
Sowers (ref_22) 2014; 816
Tam (ref_9) 2013; 19
Sajadian (ref_26) 2015; 7
Saloustros (ref_50) 2010; 6
ref_40
Katz (ref_36) 2018; 135
Takano (ref_44) 2016; 16
Ku (ref_46) 2016; 64
Kim (ref_43) 2011; 54
Lee (ref_49) 2017; 17
Chatterjee (ref_32) 2018; 1861
Durnez (ref_41) 2006; 49
References_xml – volume: 17
  start-page: 1
  year: 2017
  ident: ref_49
  article-title: The correlation between poor prognosis and increased yes-associated protein 1 expression in keratin 19 expressing hepatocellular carcinomas and cholangiocarcinomas
  publication-title: BMC Cancer
  doi: 10.1186/s12885-017-3431-1
– volume: 71
  start-page: 209
  year: 2011
  ident: ref_51
  article-title: TTF-1 mRNA-positive circulating tumor cells in the peripheral blood predict poor prognosis in surgically resected non-small cell lung cancer patients
  publication-title: Lung Cancer
  doi: 10.1016/j.lungcan.2010.04.017
– volume: 64
  start-page: 966
  year: 2016
  ident: ref_46
  article-title: Keratins: Biomarkers and modulators of apoptotic and necrotic cell death in the liver
  publication-title: Hepatology
  doi: 10.1002/hep.28493
– volume: 10
  start-page: 1
  year: 2017
  ident: ref_10
  article-title: Uncoordinated expression of DNA methylation-related enzymes in human cancer
  publication-title: Epigenetics Chromatin
  doi: 10.1186/s13072-017-0170-0
– volume: 12
  start-page: 1
  year: 2019
  ident: ref_38
  article-title: PRDM14 controls X-chromosomal and global epigenetic reprogramming of H3K27me3 in migrating mouse primordial germ cells
  publication-title: Epigenetics Chromatin
  doi: 10.1186/s13072-019-0284-7
– volume: 15
  start-page: 278
  year: 2018
  ident: ref_21
  article-title: Ten-eleven translocation 1 dysfunction reduces 5-hydroxymethylcytosine expression levels in gastric cancer cells
  publication-title: Oncol. Lett.
– volume: 45
  start-page: 708
  year: 2012
  ident: ref_33
  article-title: R loops: Lassoing DNA methylation at CpGi
  publication-title: Mol. Cell
  doi: 10.1016/j.molcel.2012.03.014
– volume: 63
  start-page: 674
  year: 2014
  ident: ref_17
  article-title: Keratin 19: A key role player in the invasion of human hepatocellular carcinomas
  publication-title: Gut
  doi: 10.1136/gutjnl-2012-304351
– volume: 279
  start-page: 651
  year: 2016
  ident: ref_3
  article-title: Management of Small Hepatocellular Carcinoma
  publication-title: Radiology
  doi: 10.1148/radiol.2016152120
– volume: 391
  start-page: 1301
  year: 2018
  ident: ref_1
  article-title: Hepatocellular carcinoma
  publication-title: Lancet
  doi: 10.1016/S0140-6736(18)30010-2
– volume: 6
  start-page: 503
  year: 2014
  ident: ref_14
  article-title: 5-hydroxymethylcytosine: A potential therapeutic target in cancer
  publication-title: Epigenomics
  doi: 10.2217/epi.14.39
– volume: 452
  start-page: 315
  year: 2014
  ident: ref_29
  article-title: Formation of covalently closed circular DNA in Hep38. 7-Tet cells, a tetracycline inducible hepatitis B virus expression cell line
  publication-title: Biochem. Biophys Res. Commun.
  doi: 10.1016/j.bbrc.2014.08.029
– volume: 69
  start-page: 639
  year: 2019
  ident: ref_27
  article-title: Integrating the epigenome to identify drivers of hepatocellular carcinoma
  publication-title: Hepatology
  doi: 10.1002/hep.30211
– volume: 94
  start-page: 479
  year: 2015
  ident: ref_34
  article-title: Identification of frequent differentially methylated region in sporadic bladder cancers
  publication-title: Urol. Int.
  doi: 10.1159/000365197
– volume: 24
  start-page: 1389
  year: 2018
  ident: ref_13
  article-title: Epigenetic reprogramming strategies to reverse global loss of 5-hydroxymethylcytosine, a prognostic factor for poor survival in high-grade serous ovarian cancer
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-17-1958
– volume: 119
  start-page: 3697
  year: 2018
  ident: ref_39
  article-title: Reduction of two histone marks, H3k9me3 and H3k27me3 by epidrug induces neuroendocrine differentiation in prostate cancer
  publication-title: J. Cell Biochem.
  doi: 10.1002/jcb.26586
– volume: 29
  start-page: 257
  year: 2014
  ident: ref_24
  article-title: Vitamin C protects against UV irradiation-induced apoptosis through reactivating silenced tumor suppressor genes p21 and p16 in a Tet-dependent DNA demethylation manner in human skin cancer cells
  publication-title: Cancer Biother. Radio
– volume: 59
  start-page: 1649
  year: 2014
  ident: ref_6
  article-title: Platelet count and survival of patients with compensated cirrhosis and small hepatocellular carcinoma treated with surgery
  publication-title: Hepatology
  doi: 10.1002/hep.26622
– volume: 60
  start-page: 1726
  year: 2013
  ident: ref_7
  article-title: The clinicopathological impact of gross classification on solitary small hepatocellular carcinoma
  publication-title: Hepato-Gastroenterol.
– volume: 152
  start-page: 1146
  year: 2013
  ident: ref_15
  article-title: Dynamic readers for 5-(hydroxy) methylcytosine and its oxidized derivatives
  publication-title: Cell
  doi: 10.1016/j.cell.2013.02.004
– volume: 91
  start-page: 262
  year: 2011
  ident: ref_45
  article-title: Epidermal growth factor induces cytokeratin 19 expression accompanied by increased growth abilities in human hepatocellular carcinoma
  publication-title: Lab. Investig.
  doi: 10.1038/labinvest.2010.161
– volume: 135
  start-page: 955
  year: 2018
  ident: ref_36
  article-title: Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrence
  publication-title: Acta Neuropathol.
  doi: 10.1007/s00401-018-1844-9
– volume: 73
  start-page: 147
  year: 2018
  ident: ref_35
  article-title: Extraskeletal osteosarcoma: MDM 2 and H3K27me3 analysis of 19 cases suggest disease heterogeneity
  publication-title: Histopathology
  doi: 10.1111/his.13506
– volume: 7
  start-page: 1
  year: 2015
  ident: ref_26
  article-title: Induction of active demethylation and 5hmC formation by 5-azacytidine is TET2 dependent and suggests new treatment strategies against hepatocellular carcinoma
  publication-title: Clin. Epigenetics
  doi: 10.1186/s13148-015-0133-x
– volume: 54
  start-page: 1707
  year: 2011
  ident: ref_43
  article-title: Human hepatocellular carcinomas with “Stemness”-related marker expression: Keratin 19 expression and a poor prognosis
  publication-title: Hepatology
  doi: 10.1002/hep.24559
– volume: 3
  start-page: 25
  year: 2016
  ident: ref_30
  article-title: Etiology and prevention of gastric cancer
  publication-title: Gastrointest Tumors
  doi: 10.1159/000443995
– volume: 70
  start-page: 7
  year: 2020
  ident: ref_2
  article-title: Cancer statistics, 2020
  publication-title: CA Cancer J. Clin.
  doi: 10.3322/caac.21590
– volume: 816
  start-page: 75
  year: 2014
  ident: ref_22
  article-title: The role of inflammation in brain cancer
  publication-title: Inflamm. Cancer
  doi: 10.1007/978-3-0348-0837-8_4
– volume: 25
  start-page: 1103
  year: 2009
  ident: ref_28
  article-title: The influences of Tet system on activity and tissue specificity of HBV Cp
  publication-title: CN J. Cell Mol. Immunol.
– ident: ref_31
  doi: 10.3390/bioengineering6030073
– volume: 138
  start-page: 43
  year: 2019
  ident: ref_37
  article-title: Molecular mechanisms of H3K27me3 and H3K4me3 in retinal development
  publication-title: Neurosci. Res.
  doi: 10.1016/j.neures.2018.09.010
– volume: 1861
  start-page: 1048
  year: 2018
  ident: ref_32
  article-title: DNA Demethylation by DNMT3A and DNMT3B in vitro and of Methylated Episomal DNA in Transiently Transfected Cells
  publication-title: BBA—Gene Regul. Mech.
– ident: ref_40
  doi: 10.1371/journal.pone.0091330
– volume: 14
  start-page: 705
  year: 2010
  ident: ref_42
  article-title: Hepatic progenitor cells: An update
  publication-title: Clin. Liver Dis.
  doi: 10.1016/j.cld.2010.08.003
– volume: 12
  start-page: 408
  year: 2015
  ident: ref_16
  article-title: Advances in targeted therapies for hepatocellular carcinoma in the genomic era
  publication-title: Nat. Rev. Clin. Oncol.
  doi: 10.1038/nrclinonc.2015.103
– volume: 12
  start-page: 2776
  year: 2020
  ident: ref_18
  article-title: Prognostic Role of Serum Cytokeratin-19 Fragment (CYFRA 21-1) in Patients with Hepatocellular Carcinoma
  publication-title: Cancers
  doi: 10.3390/cancers12102776
– volume: 19
  start-page: 1438
  year: 2013
  ident: ref_9
  article-title: The epigenetics of epithelial-mesenchymal plasticity in cancer
  publication-title: Nat. Med.
  doi: 10.1038/nm.3336
– volume: 6
  start-page: 715
  year: 2013
  ident: ref_19
  article-title: Cytosine 5-hydroxymethylation of the LZTS1 gene is reduced in breast cancer
  publication-title: Transl. Oncol.
  doi: 10.1593/tlo.13523
– volume: 21
  start-page: 3081
  year: 2015
  ident: ref_47
  article-title: Keratin 19, a cancer stem cell marker in human hepatocellular carcinoma
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-14-1936
– volume: 239
  start-page: 828
  year: 2004
  ident: ref_48
  article-title: Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes correlates with traditional predictors of prognosis: An interim analysis of a prospective multi-institutional cohort study
  publication-title: Ann. Surg.
  doi: 10.1097/01.sla.0000128687.59439.d6
– volume: 9
  start-page: 1153
  year: 2017
  ident: ref_23
  article-title: The influence of an epigenetics diet on the cancer epigenome
  publication-title: Epigenomics
  doi: 10.2217/epi-2017-0077
– volume: 49
  start-page: 138
  year: 2006
  ident: ref_41
  article-title: The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin
  publication-title: Histopathology
  doi: 10.1111/j.1365-2559.2006.02468.x
– volume: 10
  start-page: 1
  year: 2018
  ident: ref_11
  article-title: Dysregulation and prognostic potential of 5-methylcytosine (5mC), 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC) levels in prostate cancer
  publication-title: Clin. Epigenetics
  doi: 10.1186/s13148-018-0540-x
– volume: 16
  start-page: 1
  year: 2016
  ident: ref_44
  article-title: Keratin 19 as a key molecule in progression of human hepatocellular carcinomas through invasion and angiogenesis
  publication-title: BMC Cancer
  doi: 10.1186/s12885-016-2949-y
– volume: 48
  start-page: 1312
  year: 2008
  ident: ref_5
  article-title: Molecular targeted therapies in hepatocellular carcinoma
  publication-title: Hepatology
  doi: 10.1002/hep.22506
– volume: 69
  start-page: 196
  year: 2019
  ident: ref_25
  article-title: Global DNA 5-hydroxymethylcytosine and 5-formylcytosine contents are decreased in the early stage of hepatocellular carcinoma
  publication-title: Hepatology
  doi: 10.1002/hep.30146
– volume: 6
  start-page: 209
  year: 2010
  ident: ref_50
  article-title: Cytokeratin 19-positive circulating tumor cells in early breast cancer prognosis
  publication-title: Future Oncol.
  doi: 10.2217/fon.09.147
– volume: 36
  start-page: 16
  year: 2016
  ident: ref_20
  article-title: Portraits of TET-mediated DNA hydroxymethylation in cancer
  publication-title: Curr. Opin. Genet. Dev.
  doi: 10.1016/j.gde.2016.01.004
– volume: 16
  start-page: 1499
  year: 2017
  ident: ref_12
  article-title: 5-Hydroxymethylcytosine in DNA repair: A new player or a red herring?
  publication-title: Cell Cycle
  doi: 10.1080/15384101.2017.1346761
– volume: 9
  start-page: 2289
  year: 2015
  ident: ref_8
  article-title: Hepatic abscess with hepatobronchial fistula following percutaneous radiofrequency ablation for hepatocellular carcinoma: A case report
  publication-title: Oncol. Lett.
  doi: 10.3892/ol.2015.3044
– volume: 39
  start-page: 1015
  year: 2016
  ident: ref_4
  article-title: Treatment of small hepatocellular carcinoma (≤2 cm) in the caudate lobe with sequential transcatheter arterial chemoembolization and radiofrequency ablation
  publication-title: Cardiovasc. Interv. Radiol.
  doi: 10.1007/s00270-016-1314-5
SSID ssj0033777
Score 2.281421
Snippet Background: 5-Hydroxymethylcytosine (5hmC) with dynamic existence possesses multiple regulatory functions. Whereas, 5hmC’s impact on small hepatocellular...
5-Hydroxymethylcytosine (5hmC) with dynamic existence possesses multiple regulatory functions. Whereas, 5hmC's impact on small hepatocellular carcinoma (SHCC)...
SourceID doaj
pubmedcentral
proquest
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Enrichment Source
Index Database
StartPage 3758
SubjectTerms 5hmC
CK19
DNA methylation
prognosis
small hepatocellular carcinoma
Title Global DNA 5hmC and CK195hmC+ Contents: A Promising Biomarker for Predicting Prognosis in Small Hepatocellular Carcinoma
URI https://www.proquest.com/docview/2584436452
https://pubmed.ncbi.nlm.nih.gov/PMC8534723
https://doaj.org/article/69e46ac244b94b9a8c6394121010b96a
Volume 28
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYhh5JL6SOl2xcq5NRispIlS85ts01YUhICbSA3oydZ2JWD1wv9-ZmxvSGm0F4C9sFjyRYzg2fGM_qGkCMrgo4uuAxOnwkVVGat9pkvgAzxgrXdRuHLq2JxIy5u5e2TVl9YE9bDA_eMOy7KIArjwArZEg6jHdhUgbBXbGrLonONwObtgqn-G5znSvVtVXAD2VTyPp-ZQ4B_7LZNUyfgMteIhcLZyCJ1wP0jb3NcK_nE-Jy_Ii8Hr5HO-tW-JnshvSEvLoe8-Fvyp4fupz-uZlTerefUJE_nP1mJF99pB0GV2s0JndHrpgbRgsGip8t6jcU5DQXHFej4NCyCxiFYfrfc0GWiv9ZmtaILsFptjX_5sWyVzrEDUYLph-Tm_Oz3fJENPRUylyveZjo4JlgIMWpumXUQzSkZOXBVIJR8DNIo7rmy5VSayFQULOqopLfGM2Nd_o7spzqF94Q6bwWzQnEB0tFRwhRti5xFFaOR3kzIdMfXyg2A49j3YlVB4IGiqP4SxYR8e5xy36Nt_GvwKQrrcSACZXcEUJ9qUJ_qf-ozIV93oq6A-8hHk0K93VQcXDOBSVo-IWqkA6M3ju-k5V0H0Q1OEDAm__AcS_xIDjgW0mAqTH8i-22zDZ_BE2rtl07pHwCg8Qjw
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Global+DNA+5hmC+and+CK195hmC%2B+Contents%3A+A+Promising+Biomarker+for+Predicting+Prognosis+in+Small+Hepatocellular+Carcinoma&rft.jtitle=Current+oncology+%28Toronto%29&rft.au=Jinhua+Jiang&rft.au=Tinghua+Yan&rft.au=Fang+Guo&rft.date=2021-09-28&rft.pub=MDPI+AG&rft.issn=1198-0052&rft.eissn=1718-7729&rft.volume=28&rft.issue=5&rft.spage=3758&rft.epage=3770&rft_id=info:doi/10.3390%2Fcurroncol28050321&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_69e46ac244b94b9a8c6394121010b96a
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1718-7729&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1718-7729&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1718-7729&client=summon